Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amphastar Pharma (AMPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 868,102
  • Shares Outstanding, K 45,980
  • Annual Sales, $ 255,170 K
  • Annual Income, $ 10,530 K
  • 36-Month Beta 1.68
  • Price/Sales 3.30
  • Price/Cash Flow 33.62
  • Price/Book 2.56

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.00 +11.06%
on 11/09/17
19.22 -1.77%
on 11/10/17
+0.38 (+2.05%)
since 10/20/17
3-Month
14.98 +25.99%
on 08/22/17
19.22 -1.77%
on 11/10/17
+3.81 (+25.28%)
since 08/21/17
52-Week
12.05 +56.68%
on 03/14/17
21.75 -13.20%
on 12/16/16
-1.23 (-6.12%)
since 11/21/16

Most Recent Stories

More News
Amphastar Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President and Bill Peters, CFO will be presenting at the 29th Annual Piper Jaffray Healthcare Conference on Wednesday,...

AMPH : 18.88 (+3.00%)
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2017

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended September 30, 2017.

AMPH : 18.88 (+3.00%)
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2017

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2017, ended September 30, 2017, after the market closes on Wednesday, November 8,...

AMPH : 18.88 (+3.00%)
Amphastar Announces Approval for Neostigmine Methylsulfate Injection, USP

Amphastar Pharmaceuticals, Inc., (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration ("FDA") granted approval of its abbreviated new drug application (ANDA) for Neostigmine Methylsulfate...

AMPH : 18.88 (+3.00%)
Amphastar Pharmaceuticals Receives FDA Approval for Sodium Bicarbonate Injection

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that on September 19, 2017, the U.S. Food and Drug Administration ("FDA") granted approval of the company's abbreviated new drug application ("ANDA")...

AMPH : 18.88 (+3.00%)
Featured Company News - Dr. Reddy's Labs Announces the Launch of Anti-Depressant and Muscle Relaxant Tablets in the US

Research Desk Line-up: Amphastar Pharma Post Earnings Coverage

RDY : 36.80 (+4.31%)
AMPH : 18.88 (+3.00%)
Amphastar Pharmaceuticals to Present at the 2017 Wells Fargo Securities Healthcare Conference

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jason Shandell, President will be presenting at the 2017 Wells Fargo Securities Healthcare Conference on Wednesday, September 6, 2017...

WFC : 54.52 (+0.87%)
AMPH : 18.88 (+3.00%)
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2017

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ended June 30, 2017.

AMPH : 18.88 (+3.00%)
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9, 2017

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2017, ended June 30, 2017, after the market closes on Wednesday, August 9, 2017,...

AMPH : 18.88 (+3.00%)
Amphastar Announces Jury Verdict in Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that a federal jury delivered a unanimous verdict in favor of Amphastar in a lawsuit brought by Momenta Pharmaceuticals, Inc. and Sandoz Inc....

MNTA : 13.65 (+3.41%)
AMPH : 18.88 (+3.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and...

See More

Key Turning Points

2nd Resistance Point 19.41
1st Resistance Point 19.15
Last Price 18.88
1st Support Level 18.49
2nd Support Level 18.09

See More

52-Week High 21.75
Last Price 18.88
Fibonacci 61.8% 18.04
Fibonacci 50% 16.90
Fibonacci 38.2% 15.76
52-Week Low 12.05

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart